Release 5 R6 Ballot (2nd Draft)

This page is part of the FHIR Specification (v5.0.0: R5 - STU v6.0.0-ballot2: Release 6 Ballot (2nd Draft) (see Ballot Notes ). This is the The current published version in it's permanent home (it will always be available at this URL). is 5.0.0 . For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B

Example MedicinalProductDefinition/example (Narrative)

Biomedical Research and Regulation Work Group Maturity Level : N/A Standards Status : Informative Compartments : No defined compartments

This is the narrative for the resource. See also the XML , JSON or Turtle format. This example conforms to the profile MedicinalProductDefinition .

Generated Narrative

Id : example

Identifier : {mpid}

Classification : ATC: B01AF02

Attached Document : (SmPC)

Master File : (Pharmacovigilence Master File)

Product Name : Equilidem 2.5 mg film-coated tablets

Name Part

part :Equilidem

type : Invented

Name Part

part :2.5 mg

type : Strength

Name Part

part :film-coated tablets

type : Form

Country & Languages

- Country Jurisdiction Language
* EU EU EN

Manufacturing & Business Operations

- Type EffectiveDate Authorization
* Batch Release 2013-03-15 --> (ongoing) 1324TZ

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.